Search results
Pfizer's Paxlovid fails as 15-day treatment for long COVID, study finds
FOX Business· 11 hours agoA 15-day course of Pfizer's COVID-19 antiviral treatment Paxlovid did not relieve symptoms of long...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 2 days agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 4 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
The chicken and egg problem of fighting another flu pandemic
WUSF 89.7· 5 hours agoIt’s not so funny, he said, when the currently stockpiled formulation against the H5N1 bird flu virus requires two shots and a whopping 90 micrograms of antigen, yet provides just middling immunity ...
US FDA expands GSK's RSV vaccine approval to adults aged 50 to 59
Reuters via Yahoo News· 2 days agoThe shot, branded Arexvy, and vaccines from rivals Pfizer and Moderna are already approved for...
New COVID-19 vaccine for fall should target JN.1 lineage, not variant, FDA panel
USA TODAY via Yahoo News· 4 days agoOfficials noted that COVID-19 is rapidly evolving. The goal of the group was to capture the virus’...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 2 days agoModerna will rival Pfizer and GSK, which launched their shots last year. Also, in June, Moderna and...
FDA Panel Recommends New COVID Vaccines For JN.1 Lineage By Fall
Forbes· 4 days agoThe FDA’s independent Vaccines and Related Biological Products Advisory Committee voted unanimously...
There's another COVID variant you should know about: KP.3 now makes up 25% of COVID cases
USA Today· 10 hours agoThe Centers for Disease Control and Prevention data shows that a new COVID variant, the KP.3...
Promising Trial Results Show New Standards In Cancer Treatment And Diagnostics Are On The Horizon
Benzinga via Yahoo Finance· 5 days agoPfizer Is Aiming To Set The Treatment Standard For Lung Cancer With encouraging results, Pfizer is...